HealthcareServices

Targeted Therapy Market Growth Projection: Expected to Surpass $158.2 Billion by 2030 at 7.6% CAGR

March 3, 2026March 3, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the targeted therapy market from 2026–2035 with trusted insights from The Business Research Company

Starting from its 2026 valuation, what market size is the Targeted Therapy Market expected to reach by 2030?

The targeted therapy market size has experienced significant expansion in recent years. It is anticipated to grow from $109.99 billion in 2025 to $118.16 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.4%. The observed growth in past periods can be credited to various elements, such as the increasing worldwide occurrence of cancer, the expansion of funding for oncology research, the rising adoption of monoclonal antibodies, advancements in molecular biology research, and the increasing approval of targeted cancer drugs.

The targeted therapy market is projected to experience robust expansion in the coming years. It is forecast to reach a valuation of $158.2 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.6%. This anticipated growth during the forecast period is largely driven by escalating investments in personalized medicine, the expanding application of AI-driven drug discovery, wider adoption of precision diagnostics, a growing need for less toxic cancer treatments, and heightened clinical trial activities within oncology. Key trends anticipated in this period encompass the accelerated development of precision oncology drugs, an increase in the selection of biomarker-based treatments, the broadening of combination targeted therapies, the rising utilization of companion diagnostics, and a sharpened focus on designing tumor-specific drugs.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9129&type=smp

What Drivers Are Driving Adoption Within The Targeted Therapy Market?

The rising incidence of cancer is anticipated to fuel the expansion of the targeted therapy market in the future. Cancer refers to a group of diseases characterized by abnormal cells that proliferate uncontrollably and can invade nearby tissues. Targeted therapy works by deactivating signals that promote cancer cell growth or by inducing these cells to self-destruct. This treatment uses drugs to precisely focus on the genes and proteins essential for cancer cell growth and survival, thereby boosting its demand. For example, data from the American Cancer Society, a US-based nonprofit cancer advocacy organization, indicated that in January 2024, cancer cases climbed to 2,001,140 from 1,958,310 in 2023, showing a 2.19% increase. Consequently, the growing occurrence of cancer is set to propel the targeted therapy market’s growth.

How Is The Targeted Therapy Market Organized Into Various Segments?

The targeted therapy market covered in this report is segmented –

1) By Type: Small Molecule Medicines, Monoclonal Antibodies

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

3) By Application: Breast Cancer, Colorectal Cancer, Leukemia, Lung Cancer, Lymphoma, Renal Cancer, Other Applications

Subsegments:

1) By Small Molecule Medicines: Tyrosine Kinase Inhibitors (TKIs), Proteasome Inhibitors, Phosphatidylinositol 3-Kinase (PI3K) Inhibitors, Other Small Molecule Therapies

2) By Monoclonal Antibodies: Immune Checkpoint Inhibitors, Antibody-Drug Conjugates (ADCs), Cytokine Blockers, Other Monoclonal Antibodies

What Long-Term Trends Are Expected To Shape The Future Of The Targeted Therapy Market?

Leading companies within the targeted therapy market are prioritizing strategic alliances to ensure dependable service delivery for their customers. A strategic alliance represents an agreement between two or more companies or organizations, wherein they collaborate or support each other to achieve their mutual objectives. For instance, in September 2023, Shine Technologies, a US-based pharmaceutical firm specializing in the production of radioactive isotopes for medical applications, collaborated with Curadh MTR Inc., an entity committed to advancing and expediting the development of molecularly targeted radiation therapies for solid tumors. This collaborative effort seeks to harness the power of radioisotopes to precisely target and eradicate cancer cells, thereby offering renewed optimism to patients and redefining the trajectory of cancer treatment.

Who Are The Major Companies Operating In The Targeted Therapy Market?

Major companies operating in the targeted therapy market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd, Merck & Co Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi SA, Bristol Myers Squibb, AstraZeneca, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Genmab A/S, Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Incorporated, Agilent Technologies Inc., Illumina Inc., Incyte Corporation, Sysmex Corporation, Exact Sciences Corporation, Seagen Inc., Exelixis Inc., Seattle Genetics Inc., Genentech Inc., Daiichi Sankyo Company Limited

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/targeted-therapy-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Targeted Therapy Market?

North America was the largest region in the targeted therapy market in 2025. The regions covered in the targeted therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Targeted Therapy Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=9129&type=smp

Browse Through More Reports Similar to the Global Targeted Therapy Market 2026, By The Business Research Company

Addictions Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/addictions-therapeutics-global-market-report

Music Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/music-therapy-global-market-report

Neoantigen Targeted Therapies Market Report 2026

https://www.thebusinessresearchcompany.com/report/neoantigen-targeted-therapies-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795